From in vivo to in vitro/in silico ADME: progress and challenges

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.1, Iss.1, 2005-06, pp. : 1-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Edtiorial [Hot Topic: In Silico ADME/Tox Models: Progress and Challenges (Guest Editors: Robert K. DeLisle and David J. Diller)]

Current Computer - Aided Drug Design, Vol. 5, Iss. 2, 2009-06 ,pp. : 69-70

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Design Tools - In Silico, In Vitro and In Vivo ADME/PK Prediction and Interpretation: Is PK in Monkey An Essential Part of a Good Human PK Prediction?

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 4, 2011-02 ,pp. : 351-357

Bentham Science Publishers

Access to resources Recommend Favorite

In Vivo-In Vitro-In Silico Pharmacokinetic Modelling in Drug Development: Current Status and Future Directions

By Pelkonen Olavi

Clinical Pharmacokinetics, Vol. 50, Iss. 8, 2011-08 ,pp. : 483-491

Adis International

Access to resources Recommend Favorite

Combined Models for Data from In Vitro-In Vivo Correlation Experiments

By Jacobs Tom

Journal of Biopharmaceutical Statistics, Vol. 18, Iss. 6, 2008-11 ,pp. : 1197-1211

Taylor & Francis Ltd

Access to resources Recommend Favorite

In Silico hERG Modeling: Challenges and Progress

Current Computer - Aided Drug Design, Vol. 5, Iss. 2, 2009-06 ,pp. : 106-121

Bentham Science Publishers

Access to resources Recommend Favorite